PSI CRO Further Strengthens Capabilities In Infectious Diseases Clinical Trials
9/4/2014 10:31:13 AM
ZUG, Switzerland--(BUSINESS WIRE)--PSI CRO, a full-service contract research organization, mentioned today that they are strengthening their clinical trial management approaches in the area of Infectious Diseases.
A therapeutically aligned infectious diseases team will support all ID studies at PSI, focused to provide optimized approaches to patient enrollment. The team will include staff from various departments including Feasibility, Medical Affairs and Project Management.
PSI has continued to grow their Infectious Diseases experience that includes new and ongoing global studies in pneumonias, complicated urinary tract infections, intra-abdominal infections, skin infections, sepsis, and other indications. In the recent weeks, PSI reached an interim enrollment objective of several hundred patients in a global community acquired pneumonia trial, completed a global trial in a complicated urinary tract infection trial, fully enrolled a Phase III intra-abdominal infection study, as well as a trial of an influenza vaccine.
Hey, check out all the research scientist jobs. Post your resume today!
comments powered by